Protagonist Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.

CEO

Dinesh V. Patel

CEODinesh V. Patel

Employees

126

Employees126

Headquarters

Newark, California

HeadquartersNewark, California

Founded

2006

Founded2006

Employees

126

Employees126

PTGX Key Statistics

Market cap

4.82B

Market cap4.82B

Price-Earnings ratio

106.27

Price-Earnings ratio106.27

Dividend yield

—

Dividend yield—

Average volume

2.19M

Average volume2.19M

High today

$77.58

High today$77.58

Low today

$75.17

Low today$75.17

Open price

$75.60

Open price$75.60

Volume

1.19M

Volume1.19M

52 Week high

$93.25

52 Week high$93.25

52 Week low

$33.31

52 Week low$33.31

PTGX News

Nasdaq 4d

Protagonist Therapeutics Reaches Analyst Target Price

In recent trading, shares of Protagonist Therapeutics Inc (Symbol: PTGX) have crossed above the average analyst 12-month target price of $71.54, changing hands...

Simply Wall St 6d

Protagonist Therapeutics, Inc.'s 51% Price Boost Is Out Of Tune With Revenues

Despite an already strong run, Protagonist Therapeutics, Inc. ( ) shares have been powering on, with a gain of 51% in the last thirty days. Looking back a bit f...

Analyst ratings

93%

of 14 ratings

Buy

92.9%

Hold

7.1%

Sell

People also own

Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.